Literature DB >> 23736972

Sub-threshold cognitive impairment in multiple sclerosis: the association with cognitive reserve.

Anthony Feinstein1, Helen Lapshin, Paul O'Connor, Krista L Lanctôt.   

Abstract

Multiple sclerosis (MS) patients with high premorbid intellect have the advantage of cognitive reserve that may mitigate the effects of cognitive decline. A fall-off in cognition may nevertheless still occur, even should it fail to meet global impairment thresholds. The present cross-sectional study explores the neurologic and behavioral characteristics of this little known group of patients. A consecutive sample of 144 MS patients underwent neuropsychological testing with the minimal assessment of cognitive function in the MS (MACFIMS) battery. Premorbid IQ was assessed with the ANART reading test. A validated algorithm based on ANART errors and verbal fluency scores was used to predict whether current cognitive function matched premorbid estimates. Three MS groups were thus defined: cognitively intact (n = 53), impaired (n = 46) and cognitively intact on the MACFIMS, but falling short of premorbid predictions (n = 45). Patients who were cognitively intact on the MACFIMS but fell short of verbal fluency predictions had higher premorbid IQ (p = 0.007) and lower EDSS (p = 0.002) than cognitively impaired, but not intact patients. They outperformed impaired patients on every MACFIMS variable, but were more impaired than intact patients on the Paced Auditory Serial Addition Test-3 (PASAT-3) (p = 0.009). They were more likely to be employed (48.9%) than the impaired (26.1%) group (p = 0.025). We defined a group of MS patients deemed cognitively intact on conventional neuropsychological testing, but who, nevertheless, had deficits relative to premorbid intellectual abilities. The high premorbid IQ in this group does not prevent, but 'softens' the impact of cognitive decline. These findings provide novel evidence supporting cognitive reserve as a protective factor in relation to cognitive dysfunction in MS.

Entities:  

Mesh:

Year:  2013        PMID: 23736972     DOI: 10.1007/s00415-013-6952-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  26 in total

1.  Verbal fluency: a NART-based equation for the estimation of premorbid performance.

Authors:  J R Crawford; J W Moore; I M Cameron
Journal:  Br J Clin Psychol       Date:  1992-09

2.  Education and the cognitive decline associated with MRI-defined brain infarct.

Authors:  J S Elkins; W T Longstreth; T A Manolio; A B Newman; R A Bhadelia; S C Johnston
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

3.  Standards for sample composition and impairment classification in neuropsychological studies of multiple sclerosis.

Authors:  Rhb Benedict
Journal:  Mult Scler       Date:  2009-07       Impact factor: 6.312

4.  Paced auditory serial-addition task: a measure of recovery from concussion.

Authors:  D M Gronwall
Journal:  Percept Mot Skills       Date:  1977-04

5.  Influence of education on the relationship between white matter lesions and cognition.

Authors:  C Dufouil; A Alpérovitch; C Tzourio
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

6.  Premorbid cognitive leisure independently contributes to cognitive reserve in multiple sclerosis.

Authors:  J F Sumowski; G R Wylie; A Gonnella; N Chiaravalloti; J Deluca
Journal:  Neurology       Date:  2010-10-19       Impact factor: 9.910

Review 7.  Minimal neuropsychological assessment of MS patients: a consensus approach.

Authors:  Ralph H B Benedict; Jill S Fischer; Cate J Archibald; Peter A Arnett; William W Beatty; Julie Bobholz; Gordon J Chelune; John D Fisk; Dawn W Langdon; Lauren Caruso; Fred Foley; Nicholas G LaRocca; Lindsey Vowels; Amy Weinstein; John DeLuca; Stephen M Rao; Frederick Munschauer
Journal:  Clin Neuropsychol       Date:  2002-08       Impact factor: 3.535

8.  Premorbid intellectual functioning, education, and brain size in traumatic brain injury: an investigation of the cognitive reserve hypothesis.

Authors:  Shelli R Kesler; Heather F Adams; Christine M Blasey; Erin D Bigler
Journal:  Appl Neuropsychol       Date:  2003

9.  Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection.

Authors:  R A Stern; S G Silva; N Chaisson; D L Evans
Journal:  Arch Neurol       Date:  1996-02

10.  Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.

Authors:  F Patti; M P Amato; M Trojano; S Bastianello; M R Tola; B Goretti; L Caniatti; E Di Monte; P Ferrazza; V Brescia Morra; S Lo Fermo; O Picconi; G Luccichenti
Journal:  Mult Scler       Date:  2009-07       Impact factor: 6.312

View more
  10 in total

Review 1.  Cognitive reserve and Alzheimer's disease.

Authors:  Wei Xu; Jin-Tai Yu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

Review 2.  Clinical relevance of brain volume measures in multiple sclerosis.

Authors:  Nicola De Stefano; Laura Airas; Nikolaos Grigoriadis; Heinrich P Mattle; Jonathan O'Riordan; Celia Oreja-Guevara; Finn Sellebjerg; Bruno Stankoff; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

3.  Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures.

Authors:  Gabriella Santangelo; Alvino Bisecco; Luigi Trojano; Rosaria Sacco; Mattia Siciliano; Alessandro d'Ambrosio; Marida Della Corte; Luigi Lavorgna; Simona Bonavita; Gioacchino Tedeschi; Antonio Gallo
Journal:  J Neurol       Date:  2018-05-26       Impact factor: 4.849

4.  A simple measure of cognitive reserve is relevant for cognitive performance in MS patients.

Authors:  Marida Della Corte; Gabriella Santangelo; Alvino Bisecco; Rosaria Sacco; Mattia Siciliano; Alessandro d'Ambrosio; Renato Docimo; Teresa Cuomo; Luigi Lavorgna; Simona Bonavita; Gioacchino Tedeschi; Antonio Gallo
Journal:  Neurol Sci       Date:  2018-05-04       Impact factor: 3.307

5.  Psychometric properties of the Italian version of the Cognitive Reserve Scale (I-CRS).

Authors:  Manuela Altieri; Mattia Siciliano; Simona Pappacena; María Dolores Roldán-Tapia; Luigi Trojano; Gabriella Santangelo
Journal:  Neurol Sci       Date:  2018-05-04       Impact factor: 3.307

6.  Thalamus volume change and cognitive impairment in early relapsing-remitting multiple sclerosis patients.

Authors:  Juan I Rojas; Georgina Murphy; Francisco Sanchez; Liliana Patrucco; Maria C Fernandez; Jimena Miguez; Jorge Funes; Angel Golimstok; Edgardo Cristiano
Journal:  Neuroradiol J       Date:  2018-06-05

7.  Longitudinal Stability of Cognition in Early-Phase Relapsing-Remitting Multiple Sclerosis: Does Cognitive Reserve Play a Role?

Authors:  Roxana M Barbu; Jason A Berard; Louise M Gresham; Lisa A S Walker
Journal:  Int J MS Care       Date:  2018 Jul-Aug

8.  Pattern separation performance is decreased in patients with early multiple sclerosis.

Authors:  Vincent Planche; Aurélie Ruet; Julie Charré-Morin; Mathilde Deloire; Bruno Brochet; Thomas Tourdias
Journal:  Brain Behav       Date:  2017-06-21       Impact factor: 2.708

9.  Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis.

Authors:  Daniela Pinter; James Sumowski; John DeLuca; Franz Fazekas; Alexander Pichler; Michael Khalil; Christian Langkammer; Siegrid Fuchs; Christian Enzinger
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

Review 10.  Recommendations for cognitive screening and management in multiple sclerosis care.

Authors:  Rosalind Kalb; Meghan Beier; Ralph Hb Benedict; Leigh Charvet; Kathleen Costello; Anthony Feinstein; Jeffrey Gingold; Yael Goverover; June Halper; Colleen Harris; Lori Kostich; Lauren Krupp; Ellen Lathi; Nicholas LaRocca; Ben Thrower; John DeLuca
Journal:  Mult Scler       Date:  2018-10-10       Impact factor: 6.312

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.